Nonradioactive single-strand conformation polymorphism analysis for detection of fluoroquinolone resistance in mycobacteria

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 16, Issue 5, 1997, Pages 395-398

  Sougakoff, W ^a   Lemaitre N ^a   Cambau, E ^a   Szpytma, M ^a   Revel, V ^a   Jarlier, V ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; CONTROLLED STUDY; DNA DETERMINATION; METHODOLOGY; MYCOBACTERIUM; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SILVER STAINING; SINGLE STRAND CONFORMATION POLYMORPHISM;

ANTI-INFECTIVE AGENTS; BASE SEQUENCE; DNA, BACTERIAL; DRUG RESISTANCE, MICROBIAL; FLUOROQUINOLONES; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SENSITIVITY AND SPECIFICITY;

EID: 0030954182     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01726372     Document Type: Article

References (18)

1. Iseman MD: Treatment of multidrug-resistance tubercu-losis. New England Journal of Medicine 1993, 9: 784-791.
2. Tsukamura M, Nakamura E, Yoshii S, Yanase M, Yasuda Y, Amano H: Therapeutic effect of a new antibacterial substance ofloxacin (DL8280) on pulmonary tuberculosis. American Review of Respiratory Diseases 1985, 131: 352-356.
3. Cambau E, Sougakoff W, Besson M, Truffot-Pernot C, Grosset J, Jarlier V: Identification of a gyrA point mutation in a strain of Mycobacterium tuberculosis resistant to fluoroquinolones selected during treatment with ofloxacin. Journal of Infectious Diseases 1994, 170: 479-483.
4. Sullivan EA, Kreiswirth BN, Palumbo L, Kapur V, Musser JM, Ebrahimzadeh A, Frieden TR: Emergence of fluoroquinolone-resistant tuberculosis in New York City. Lancet 1995, 345: 1148-1150.
5. Alangaden GJ, Manavathu EK, Vakulenko SB, Zvonok NM, Lerner SA: Characterization of fluoroquinolone-resistant mutant strains of Mycobacterium tuberculosis selected in the laboratory and isolated from patients. Antimicrobial Agents and Chemotherapy 1995, 39: 1700-1703.
6. Cambau E, Sougakoff W, Jarlier V: Amplification and nucleotide sequence of the quinolone resistance-determining region in the gyrA gene of mycobacteria. FEMS Microbiology Letters 1994, 116: 49-54.
7. Revel V, Cambau E, Jarlier V, Sougakoff W: Characterization of mutations involved in resistance to fluoroquinolones in Mycobacterium smegmatis. Antimicrobial Agents and Chemotherapy 1994, 38: 1991-1996.
8. Takiff HE, Salazar L, Guerrero C, Philipp W, Huang WM, Kreiswirth B, Cole ST, Jacobs WR, Telenti A: Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations. Antimicrobial Agents and Chemotherapy 1994, 38: 773-780.
9. Kocagöz T, Hackbarth CJ, Ünsal I, Rosenberg EY, Nikaido H, Chambers HF: Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra. Antimicrobial Agents and Chemotherapy 1996, 40: 1768-1774.
10. Takiff HE, Cimino M, Musso MC, Weisbrod T, Martinez R, Delgado MB, Salazar L, Bloom BR, Jacobs WR: Efflux pump of the proton antiporter family confers low-level fluoroquinolone resistance in Mycobacterium smegmatis. Proceedings of the National Academy of Sciences of the USA 1996, 93: 362-366.
11. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T: Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphism. Proceedings of the National Academy of Sciences of the USA 1989, 86: 2766-2770.
12. Delgado MB, Telenti A: Detection of mutations associated with quinolone resistance in Mycobacterium tuberculosis. In: Persing DH (ed): Selected PCR protocols for emerging infectious diseases. American Society for Microbiology, Washington DC, 1996.
13. Cooksey RC, Morlock GR McQueen A, Glickman SE, Crawford JT: Characterization of streptomycin resistance mechanisms among Mycobacterium tuberculosis isolates from patients in New York City. Antimicrobial Agents and Chemotherapy 1996, 40: 1186-1188.
14. Tokue Y, Sugano K, Saito D, Noda T, Ohkura H, Shimosato Y, Sekiya T: Detection of novel mutations in the gyrA gene of Staphylococcus aureus by nonradioisotopic single-strand conformation polymorphism analysis and direct DNA sequencing. Antimicrobial Agents and Chemotherapy 1994, 38: 428-431.
15. Ouabdesselam S, Hooper D, Tankovic J, Soussy CJ: Detection of gyrA and gyrB mutations in quinolone-resistant clinical isolates of Escherichia coli by single-strand conformational polymorphism analysis and determination of levels of resistance conferred by two different single gyrA mutations. Antimicrobial Agents and Chemotherapy 1995, 39: 1667-1670.
16. Woods SA, Cole ST: A rapid method for the detection of potentially viable Mycobacterium leprae in human biopsies: a novel application of PCR. FEMS Microbiology Letters 1990, 65: 305-310.
17. Hongyo T, Buzard GS, Calvert RJ, Weghorst CM: 'Cold SSCP': a simple, rapid and non-radioactive method for optimized single-strand conformation polymorphism analyses. Nucleic Acids Research 1993, 21: 3637-3642.
18. Yoshida H, Bogaki M, Nakamura M, Nakamura S: Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrobial Agents and Chemotherapy 1990, 34: 1271-1272.